MMP9 and nonpapillary renal cell carcinoma: With the employment of the Clinical Proteomic Tumor Analysis Consortium (CPTAC), the protein level of MMP9 and Vimentin were positively associated with CD44 in ccRCC tissues (Fig. 7F).